Acme Universal Safezone 9 IPO: Complete Analysis, Financials, and Investment Details
The Small and Medium Enterprise (SME) sector is witnessing continuous growth, offering intriguing investment avenues for market participants. The upcoming Acme Universal Safezone 9 IPO has recently captured the market's attention. Operating in the critical Personal Protective Equipment (PPE) segment, the company is looking to raise funds to expand its operations and scale its market presence.
In this comprehensive guide, we will delve deeply into the company’s background, vital IPO dates, valuation metrics, financial performance, and a thorough SWOT analysis to help you understand the core dynamics of this public issue.
Company Overview: What Does Acme Universal Safezone 9 Do?
Originally beginning its business operations as a partnership firm in April 1994 and later incorporating as a public entity in November 2016, Acme Universal Safezone 9 Limited has established itself as a premier manufacturer of industrial safety footwear under the popular 'ACME' brand.
The company provides vital safety solutions across high-risk industries, including oil & gas, construction, mining, pharmaceuticals, power generation, and automotive. Their comprehensive product line includes PVC, Nitrile Rubber, and EVA-Rubber safety shoes, which strictly adhere to national and global standards such as IS 15298, ASTM F2413, EN ISO 20345, and SEDEX SMETA.
Backed by robust technology, the firm utilizes SAP S/4 HANA ERP, ICad3D design software, and operates five state-of-the-art manufacturing plants located in Uttar Pradesh and Madhya Pradesh. With a massive workforce of 1,073 professionals (as of March 2026), the company not only caters to domestic demand through institutional and e-commerce channels but also exports its goods to multiple nations, including Saudi Arabia, UAE, Israel, Nigeria, and the Netherlands.
Acme Universal Safezone 9 IPO Snapshot
The company is launching a 100% fresh issue book-built SME IPO aimed at raising ₹35.93 crores. Below is a quick glance at the primary issue details.
| Particulars | Details |
|---|---|
| IPO Type | Book Built Issue (SME) |
| Total Issue Size | ₹35.93 Crores (50,60,800 Equity Shares) |
| Fresh Issue Size | ₹35.93 Crores (50,60,800 Equity Shares) |
| Price Band | ₹65 to ₹71 per share |
| Face Value | ₹10 per share |
| Listing Exchange | BSE SME |
IPO Timetable & Status Progress
Staying updated with crucial dates is a fundamental requirement for active market participants. The bidding process begins in late September 2026. Here is the scheduled timeline for the issue:
Investment Application Lot Sizes
Market guidelines mandate a specific minimum application volume for SME public issues. For this IPO, the base lot size is set at 1,600 shares; however, the minimum bidding application for a retail investor starts at 2 lots.
| Investor Category | Minimum Lots | Shares | Investment Amount (at Upper Band) |
|---|---|---|---|
| Retail Individual (Min) | 2 Lots | 3,200 Shares | ₹2,27,200 |
| Retail Individual (Max) | 2 Lots | 3,200 Shares | ₹2,27,200 |
| S-HNI (Min) | 3 Lots | 4,800 Shares | ₹3,40,800 |
| S-HNI (Max) | 8 Lots | 12,800 Shares | ₹9,08,800 |
| B-HNI (Min) | 9 Lots | 14,400 Shares | ₹10,22,400 |
Financial Health and Performance Tracking
Reviewing historical financial trends is essential for gauging a company’s operational stability. Acme Universal Safezone 9 has showcased substantial growth, recovering from a minor dip in profits during FY 2025 to achieve a massive surge in FY 2026.
| Financial Metrics (₹ in Crores) | FY 2026 (Mar 31) | FY 2025 (Mar 31) | FY 2024 (Mar 31) |
|---|---|---|---|
| Total Assets | 146.72 | 133.70 | 119.07 |
| Total Revenue | 211.16 | 191.31 | 181.67 |
| Profit After Tax (PAT) | 5.86 | 0.80 | 7.56 |
| Net Worth | 52.77 | 46.91 | 41.96 |
| Total Borrowing | 58.05 | 49.65 | 44.51 |
Note: Revenue grew by roughly 10% in FY 2026, while the Profit After Tax observed an impressive 628% leap compared to FY 2025 figures.
Key Performance & Valuation Metrics
Investors often look at key performance indicators (KPIs) to analyze the fair pricing of the shares. Based on the data leading up to FY 2026, here are the valuation figures:
- Pre-IPO EPS: ₹4.17
- Post-IPO EPS: ₹3.07
- Pre-IPO P/E Ratio: 17.03x
- Post-IPO P/E Ratio: 23.13x
- Return on Net Worth (RoNW): 11.75%
- Debt-to-Equity Ratio: 1.10
- Market Capitalization (Post-Issue): ~₹135.56 Crores
Capital Utilization: Objectives of the IPO
The company plans to strategically deploy the net proceeds generated from this fresh capital influx. The allocation is planned as follows:
| Strategic Objective | Estimated Allocation (₹ in Cr) |
|---|---|
| Installation of additional manufacturing machinery | 8.96 |
| Fulfilling incremental working capital requirements | 8.00 |
| Installation of a captive solar power plant | 3.62 |
| General corporate purposes & strategic acquisitions | Balance Proceeds |
Promoters and Shareholding Pattern
The leadership core of Acme Universal Safezone 9 consists of Nitin Tiwari and Ruchi Tiwari, who act as the primary promoters of the organization.
- Pre-Issue Promoter Holding: 94.88%
- Post-Issue Market Availability: Given the structure, public float will constitute around 5.12% post-dilution, signifying strong skin-in-the-game from the founding team.
Strategic SWOT Analysis
To provide a balanced perspective, here is a strategic evaluation of the firm's internal capabilities and external market environment:
Strengths
- Large-scale infrastructure with 5 dedicated manufacturing units.
- Adherence to global quality compliances enabling seamless international exports.
- Technologically advanced operations utilizing ERP, HRMS, and CRM software.
Weaknesses
- Moderate dependency on borrowings (₹58.05 Cr total debt in FY26), yielding a Debt/Equity ratio of 1.10.
- Earnings volatility witnessed historically (PAT dropped significantly in FY25 before rebounding).
Opportunities
- Installation of solar infrastructure could substantially optimize operational power costs.
- Rising global awareness around industrial safety and stringent PPE compliance frameworks.
- Scope for aggressive international expansion across emerging markets.
Threats
- Intense competition from unorganized and international footwear manufacturers.
- Vulnerability to raw material cost fluctuations (rubber, PVC, EVA).
Company Contact & Registrar Details
If you require further clarifications regarding the public issue or allotment status, you can reach out to the official handlers:
| Entity | Contact Information |
|---|---|
| Registrar to the Issue | Maashitla Securities Pvt. Ltd. Phone: 011-45121795 Email: investor.ipo@maashitla.com |
| Lead Manager | Expert Global Consultants Pvt. Ltd. |
| Company Registered Office | Near Twelve Shops, Girwai Naka, A.B. Road, Gwalior, Madhya Pradesh - 474001 Email: compliance@acmeuniversal9.com |
Concluding Thoughts
The Acme Universal Safezone 9 IPO presents an opportunity to gain exposure to the rapidly expanding PPE and industrial safety sector. With robust manufacturing capabilities and an expanding global footprint, the company holds strong long-term potential. However, general market participants must carefully evaluate the issue's valuation multiples and current debt levels before aligning this opportunity with their individual financial strategies. We hope this comprehensive guide on Publiclisting.in provided you with clear, data-driven insights into this upcoming SME offering.